Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Battle for the Ages

As I was watching the pompom news channel (CNBC), they went into full damage control over Thursday's massacre, and I thought to myself, "What markets or media bullet points do 'the boys' need to control today in order to avoid a weekly sell signal and ensuing panic?" In...

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

Real Estate Crash The Next Shoe To Drop – Part II

As we continue to delve into the looming Real Estate crisis that will likely hit the US and globe over the next 12 to 24+ months, we want to focus on the human psychological process of dealing with a crisis event and how that relates to economic engagement. In the first part...

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...

Will 2020 be junior mining’s year?

Another year of covering commodities and select junior mining stocks is all but done and dusted. We’ve seen palladium prices more than double those of platinum, its sister metal, on tight supply and high demand for catalytic converters in gas-powered ve...

World's major gold miners target copper porphyries

Something has changed in the gold industry. During high gold-price periods the trend was to produce as much as possible - in many cases, irrespective of higher extraction costs per ounce. In a way you can’t blame them for making hay while the sun shone. The g...

Deflation or Inflation: Gold Doesn't Care

Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price. In our view, gold investors should settle back with some popcorn and enjoy the coming fireworks, which will include the best gold bull market ...

Gold Leads, Will the Rest Follow?

The natural resource landscape has shifted dramatically since the end of 2018. At the time, we were still nursing our wounds from an unexpectedly vicious 2018 and hoping to avoid a repeat performance in 2019. I did speculate that "we may have already exited the bear mar...

Junior’s are the answer to gold industry challenges

Back in May, AngloGold Ashanti announced plans to sell its last remaining gold mine in South Africa, the Mponeng mine southwest of Johannesburg. Despite extremely rich 10 grams per tonne ore, “the challenges of making money at Mponeng are immense,” st...

Us Stocks Seem To Be Following Our Predictions – Get Ready (Part I)

As we near the important date of August 19, 2019, and we watch how the markets are reacting based on our earlier predictions, it is becoming evident that the US stock markets and global stock markets are following our predictions very well. The fact that these markets are doin...
1 2